Imagine a time when the term "biotech startup" was virtually unheard of in Germany, and venture capital was a distant dream. In a landscape where the path from groundbreaking research to market success was shrouded in uncertainty, Professor Detlev Riesner co-founded Qiagen, the first German company to list on Nasdaq and later become a DAX member.
👉 Vant…
Listen to this episode with a 7-day free trial
Subscribe to Startuprad.io’s Newsletter to listen to this post and get 7 days of free access to the full post archives.
